Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Sasya Bio is an animal nutrition and health company that uses fermentation and microbial genetics to produce dietary supplements aimed at improving animal performance and profitability. Its products apply across species including humans, companion animals, and fish, with an initial focus on the swine and poultry markets.
0 investors
0 investors
0 investors
0 investors
Savara is a biopharmaceutical company developing product candidates for the treatment of autoimmune pulmonary alveolar proteinosis and related conditions. The company operates as a clinical-stage pharmaceutical developer focused on bringing therapeutic solutions to patients with rare and serious diseases.
0 investors
0 investors
Scalpel Ventures is a venture capital firm that invests in healthcare companies, with a focus on musculoskeletal care, cartilage regeneration, and sports medicine. It offers investors deal-by-deal opportunity selection with visibility into performance.
0 investors
ScienceMedia provides results-oriented clinical training for the life sciences industry, aimed at improving stakeholders' clinical knowledge. It serves pharmaceutical and life sciences companies as an industry partner.
0 investors
Scientific Industries sells laboratory equipment including vortex mixers, rotators, rockers, disruptors, and shakers under the GENIE brand for sample mixing, agitation, and cell disruption. It supplies these instruments directly from its own warehouse to laboratory and research users, primarily in the U.S.
0 investors
0 investors
Scienture Holdings operates and manages pharmaceutical companies that develop and commercialize specialty pharmaceutical products for underserved patient populations. The company focuses on addressing unmet medical needs through novel drug concepts, manufacturing expertise, and integrated sales and marketing capabilities.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Vivani develops miniaturized, long-acting subdermal drug implants using its NanoPortal technology to deliver steady doses of medication over months, addressing medication adherence challenges in chronic disease. Its pipeline targets chronic weight management and type 2 diabetes with semaglutide-based implants.
0 investors
Secura Bio develops and commercializes oncology therapies for difficult-to-treat patient populations. The company leverages extensive experience in clinical development and market launch to bring life-prolonging cancer medicines to patients.
0 investors
0 investors
0 investors